title: [Antihypertensive drug trials also reveal renoprotective effects].
abstract: The author analyzes the applicability of the renin-angiotensin system blocking drugs in patients with chronic kidney disease emphasizing their renoprotective (blood pressure and albuminuria lowering) and cardiovascular risk decreasing effects. As opposed to a previously-published statement, the author believes that their application is fundamental, particularly in combination with calcium-antagonist drugs. Relying on many references the author suggests that combined treatment with different renin-angiotensin system blocking drugs cannot be entirely ruled out, although it is not yet recommended.
authors: Szent Imre Oktató Kórház Nephrologia-Hypertonia Profil Budapest. ikiss@enternet.hu
authors: István
authors: I
authors: Kiss
mesh_terms: D000419:Albuminuria / Q000188:drug therapy / Q000209:etiology; D057911:Angiotensin Receptor Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D003928:Diabetic Nephropathies / Q000188:drug therapy; D006801:Humans; D020011:Protective Agents / Q000494:pharmacology / Q000627:therapeutic use*; D051436:Renal Insufficiency, Chronic / Q000150:complications / Q000517:prevention & control*; D012084:Renin-Angiotensin System / Q000187:drug effects*; D012307:Risk Factors; D012720:Severity of Illness Index
chemical_list: D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D020011:Protective Agents